Dorman Products (DORM) director awarded 1,344 restricted stock units in Form 4 filing
Rhea-AI Filing Summary
Stakias G. Michael reported acquisition or exercise transactions in this Form 4 filing.
Dorman Products director G. Michael Stakias received an equity award rather than buying shares on the market. He was granted 1,344 restricted stock units representing a contingent right to receive an equal number of Dorman common shares at a reference price of $122.71 per share. The units vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of shareholders. Following this award, he beneficially owns 16,150 shares of common stock directly.
Positive
- None.
Negative
- None.
Insights
Director received routine stock-based compensation through restricted stock units.
The filing shows director G. Michael Stakias acquired 1,344 restricted stock units, a form of stock-based compensation rather than an open-market purchase. These units represent a contingent right to receive Dorman common shares at a reference value of $122.71 per share.
The units vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting of shareholders, aligning the director’s interests with shareholders over that period. After this grant, he holds 16,150 shares directly, indicating the transaction is modest relative to his overall stake.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,344 | $122.71 | $165K |
Footnotes (1)
- F1. Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
Form 4 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.